Fill gaps in clinical trial data by generating missing modalities; Reduce assay costs by predicting profiles from routine data; Enable rare disease research through synthesized data types; Accelerate biomarker discovery with imputed molecular markers
Founder/CTO
Backed by Y Combinator; Focused on multimodal data for biological insights; Serves life sciences teams in various research capacities